{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:40:44Z","timestamp":1769269244956,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02863-y","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T19:02:01Z","timestamp":1715281321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Examining treatment strategies for xanthelasma palpebrarum: a comprehensive literature review of contemporary modalities"],"prefix":"10.1007","volume":"316","author":[{"given":"Danielle A.","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert E.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amor","family":"Khachemoune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"key":"2863_CR1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5507\/bp.2014.016","volume":"158","author":"A Zak","year":"2014","unstructured":"Zak A, Zeman M, Slaby A, Vecka M (2014) Xanthomas: clinical and pathophysiological relations. Biomed Pap 158:181\u2013188","journal-title":"Biomed Pap"},{"key":"2863_CR2","unstructured":"Bell A, Shreenath AP. Xanthoma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Mar 24]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562241\/"},{"key":"2863_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0190-9622(88)70157-7","volume":"19","author":"PD Cruz","year":"1988","unstructured":"Cruz PD, East C, Bergstresser PR (1988) Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol 19:95\u2013111","journal-title":"J Am Acad Dermatol"},{"key":"2863_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/0973-029X.125205","volume":"17","author":"U Hegde","year":"2013","unstructured":"Hegde U, Doddawad VG, Sreeshyla H, Patil R (2013) Verruciform xanthoma: a view on the concepts of its etiopathogenesis. J Oral Maxillofac Pathol JOMFP 17:392\u2013396","journal-title":"J Oral Maxillofac Pathol JOMFP"},{"key":"2863_CR5","unstructured":"Al Aboud AM, Shah SS, Al Aboud DM. Xanthelasma palpebrarum. StatPearls [Internet]. treasure island (FL): StatPearls Publishing. 2022 [cited 2023 Jan 26]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK531501\/"},{"key":"2863_CR6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/postgradmedj-2011-130443","volume":"88","author":"D Pandhi","year":"2012","unstructured":"Pandhi D, Gupta P, Singal A, Tondon A, Sharma S, Madhu SV (2012) Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J 88:198\u2013204","journal-title":"Postgrad Med J"},{"key":"2863_CR7","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1172\/JCI106436","volume":"49","author":"F Parker","year":"1970","unstructured":"Parker F, Bagdade JD, Odland GF, Bierman EL (1970) Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest 49:2172\u20132187","journal-title":"J Clin Invest"},{"key":"2863_CR8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jacl.2014.05.004","volume":"8","author":"L Baila-Rueda","year":"2014","unstructured":"Baila-Rueda L, Mateo-Gallego R, Lamiquiz-Moneo I, Cenarro A, Civeira F (2014) Severe hypercholesterolemia and phytosterolemia with extensive xanthomas in primary biliary cirrhosis: role of biliary excretion on sterol homeostasis. J Clin Lipidol 8:520\u2013524","journal-title":"J Clin Lipidol"},{"key":"2863_CR9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0002-9343(99)80224-1","volume":"99","author":"M Ribera","year":"1995","unstructured":"Ribera M, Pint\u00f3 X, Argimon JM, Fiol C, Pujol R, Ferr\u00e1ndiz C (1995) Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 99:485\u2013490","journal-title":"Am J Med"},{"key":"2863_CR10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(94)70023-0","volume":"30","author":"R Bergman","year":"1994","unstructured":"Bergman R (1994) The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 30:236\u2013242","journal-title":"J Am Acad Dermatol"},{"key":"2863_CR11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5999\/aps.2013.40.4.380","volume":"40","author":"HY Lee","year":"2013","unstructured":"Lee HY, Jin US, Minn KW, Park Y-O (2013) Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg 40:380\u2013386","journal-title":"Arch Plast Surg"},{"key":"2863_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0032-1329413","volume":"26","author":"J Preissig","year":"2012","unstructured":"Preissig J, Hamilton K, Markus R (2012) Current laser resurfacing technologies: a review that delves beneath the surface. Semin Plast Surg 26:109\u2013116","journal-title":"Semin Plast Surg"},{"key":"2863_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/14764172.2016.1256488","volume":"19","author":"A Balevi","year":"2017","unstructured":"Balevi A, Ustuner P, Ozdemir M (2017) Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum. J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol 19:100\u2013105","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"key":"2863_CR14","first-page":"131","volume":"39","author":"H Tuan","year":"2021","unstructured":"Tuan H, Chen Y, Yang S, Liu D, Chen D, Zhao Y (2021) A comparison of efficacy and safety of fractional carbon dioxide laser and fractional Er:YAG laser for the treatment of xanthelasma palpebrarum: a two-center randomized split-face controlled trial. Photobiomodul Photomed Laser Surg 39:131\u2013136","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"2863_CR15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jocd.12137","volume":"14","author":"K Goel","year":"2015","unstructured":"Goel K, Sardana K, Garg VK (2015) A prospective study comparing ultrapulse CO2 laser and trichloroacetic acid in treatment of Xanthelasma palpebrarum. J Cosmet Dermatol 14:130\u2013139","journal-title":"J Cosmet Dermatol"},{"key":"2863_CR16","doi-asserted-by":"crossref","unstructured":"Mourad B, Elgarhy LH, Ellakkawy H-A, Elmahdy N (2015) Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum. J Cosmet Dermatol 14:209\u201315.","DOI":"10.1111\/jocd.12148"},{"key":"2863_CR17","doi-asserted-by":"crossref","unstructured":"Konstantinou MP, Evangelou G, Hegazy S, Krasagakis K, Bulai-Livideanu C (2022) Comparison of the efficacy and safety of continuous CO2 laser and 1064\u2009nm Q-switched Nd:YAG Laser for the treatment of xanthelasma palpebrarum. Int J Dermatol.","DOI":"10.1111\/ijd.16475"},{"key":"2863_CR18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0733-8635(05)70286-2","volume":"19","author":"TS Alster","year":"2001","unstructured":"Alster TS, Lupton JR (2001) Erbium:YAG cutaneous laser resurfacing. Dermatol Clin 19:453\u2013466","journal-title":"Dermatol Clin"},{"key":"2863_CR19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/09546634.2013.777153","volume":"25","author":"S G\u00fcng\u00f6r","year":"2014","unstructured":"G\u00fcng\u00f6r S, Canat D, G\u00f6kdemir G (2014) Erbium: YAG laser ablation versus 70% trichloroacet\u0131c acid application in the treatment of xanthelasma palpebrarum. J Dermatol Treat 25:290\u2013293","journal-title":"J Dermatol Treat"},{"key":"2863_CR20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaad.2017.03.041","volume":"77","author":"JK Heng","year":"2017","unstructured":"Heng JK, Chua SH, Goh CL, Cheng S, Tan V, Tan WP (2017) Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser. J Am Acad Dermatol 77:728\u2013734","journal-title":"J Am Acad Dermatol"},{"key":"2863_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/14764172.2020.1761551","volume":"22","author":"JH Park","year":"2020","unstructured":"Park JH, Ryu SI, Kim I-H (2020) Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum. J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol 22:141\u2013145","journal-title":"J Cosmet Laser Ther Off Publ Eur Soc Laser Dermatol"},{"key":"2863_CR22","first-page":"557","volume":"144","author":"EF Bernstein","year":"2009","unstructured":"Bernstein EF (2009) The pulsed-dye laser for treatment of cutaneous conditions. G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr 144:557\u2013572","journal-title":"G Ital Dermatol E Venereol Organo Uff Soc Ital Dermatol E Sifilogr"},{"key":"2863_CR23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/JCAS.JCAS_184_18","volume":"12","author":"CP Thajudheen","year":"2019","unstructured":"Thajudheen CP, Jyothy K, Arul P (2019) Treatment of xanthelasma palpebrarum using pulsed dye laser: original report on 14 cases. J Cutan Aesthetic Surg 12:193\u2013195","journal-title":"J Cutan Aesthetic Surg"},{"key":"2863_CR24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/jama.1981.03310450057027","volume":"245","author":"DB Apfelberg","year":"1981","unstructured":"Apfelberg DB, Maser MR, Lash H, Rivers J (1981) The argon laser for cutaneous lesions. JAMA 245:2073\u20132075","journal-title":"JAMA"},{"key":"2863_CR25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.sjopt.2014.09.017","volume":"29","author":"M Abdelkader","year":"2015","unstructured":"Abdelkader M, Alashry SE (2015) Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum. Saudi J Ophthalmol Off J Saudi Ophthalmol Soc 29:116\u2013120","journal-title":"Saudi J Ophthalmol Off J Saudi Ophthalmol Soc"},{"key":"2863_CR26","first-page":"860","volume":"42","author":"E Greijmans","year":"2016","unstructured":"Greijmans E, Luiting-Welkenhuyzen H, Luijks H, Bovenschen HJ (2016) Continuous wave potassium titanyl phosphate laser treatment is safe and effective for xanthelasma palpebrarum. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 42:860\u2013866","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"2863_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jocd.12509","volume":"18","author":"A Baroni","year":"2019","unstructured":"Baroni A (2019) Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum. J Cosmet Dermatol 18:121\u2013123","journal-title":"J Cosmet Dermatol"},{"key":"2863_CR28","doi-asserted-by":"crossref","unstructured":"Singh A, Tiwary PK, Jha AK, Zeeshan Md, Ranjan A (2020) Successful treatment of xanthelasma palpebrarum with a combination of radiofrequency ablation and wound suturing. J Cosmet Dermatol 19:3286\u201390","DOI":"10.1111\/jocd.13678"},{"key":"2863_CR29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/ijd.15110","volume":"59","author":"PC Friedman","year":"2020","unstructured":"Friedman PC (2020) Cold atmospheric pressure (physical) plasma in dermatology: where are we today? Int J Dermatol 59:1171\u20131184","journal-title":"Int J Dermatol"},{"key":"2863_CR30","first-page":"55","volume":"29","author":"S Rubins","year":"2020","unstructured":"Rubins S, Ritina I, Jakus J, Rubins A (2020) Plasma sublimation for the treatment of xanthelasma palpebrarum. Acta Dermatovenerol Alp Pannonica Adriat 29:55\u201357","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"2863_CR31","first-page":"181","volume":"35","author":"A Scarano","year":"2021","unstructured":"Scarano A, Inchingolo F, Scogna G, Leo L, Crisante A, Greco Lucchina A et al (2021) Xanthelasma palpebrarum removed with Atmospheric Plasma technique: 11-year follow up. J Biol Regul Homeost Agents 35:181\u2013185","journal-title":"J Biol Regul Homeost Agents"},{"key":"2863_CR32","volume":"12","author":"F Tan","year":"2022","unstructured":"Tan F, Wang Y, Zhang S, Shui R, Chen J (2022) Plasma dermatology: skin therapy using cold atmospheric plasma. Front Oncol 12:918484","journal-title":"Front Oncol"},{"key":"2863_CR33","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00266-013-0195-0","volume":"37","author":"Y Yang","year":"2013","unstructured":"Yang Y, Sun J, Xiong L, Li Q (2013) Treatment of xanthelasma palpebrarum by upper eyelid skin flap incorporating blepharoplasty. Aesthetic Plast Surg 37:882\u2013886","journal-title":"Aesthetic Plast Surg"},{"key":"2863_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2310\/7750.2012.12065","volume":"17","author":"R Kose","year":"2013","unstructured":"Kose R (2013) Treatment of large xanthelasma palpebrarums with full-thickness skin grafts obtained by blepharoplasty. J Cutan Med Surg 17:197\u2013200","journal-title":"J Cutan Med Surg"},{"key":"2863_CR35","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1097\/SCS.0000000000003830","volume":"28","author":"B Obradovic","year":"2017","unstructured":"Obradovic B (2017) Surgical treatment as a first option of the lower eyelid xanthelasma. J Craniofac Surg 28:e678\u2013e679","journal-title":"J Craniofac Surg"},{"key":"2863_CR36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/dth.12254","volume":"28","author":"J Labandeira","year":"2015","unstructured":"Labandeira J, V\u00e1zquez-Osorio I, Figueroa-Silva O, Pereiro M, Toribio J (2015) Tolerability and effectiveness of liquid nitrogen spray cryotherapy with very short freeze times in the treatment of xanthelasma palpebrarum. Dermatol Ther 28:346\u2013350","journal-title":"Dermatol Ther"},{"key":"2863_CR37","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0190-9622(88)70210-8","volume":"19","author":"JE Sebben","year":"1988","unstructured":"Sebben JE (1988) The status of electrosurgery in dermatologic practice. J Am Acad Dermatol 19:542\u2013549","journal-title":"J Am Acad Dermatol"},{"key":"2863_CR38","first-page":"891","volume":"15","author":"K Sansalone","year":"2016","unstructured":"Sansalone K, Beer K, Pavlis J (2016) Effective treatment of xanthelasma. J Drugs Dermatol JDD 15:891\u2013892","journal-title":"J Drugs Dermatol JDD"},{"key":"2863_CR39","doi-asserted-by":"crossref","unstructured":"Al-Kady NA-S, Hamdino M, Abdel Kawy FAW (2021) Fractional CO2 laser versus trichloroacetic acid 50% for xanthelasma palpebrarum therapy. J Cosmet Dermatol. 20:763\u20138","DOI":"10.1111\/jocd.13666"},{"key":"2863_CR40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/0974-2077.197073","volume":"9","author":"PKS Reddy","year":"2016","unstructured":"Reddy PKS, Kunneth ST, Lakshminarayana SPA, Yallappa SM, Chandrashekara R, Nanjundaswamy SK (2016) Comparative study to evaluate the efficacy of radiofrequency ablation versus trichloroacetic acid in the treatment of xanthelasma palpebrarum. J Cutan Aesthetic Surg 9:236\u2013240","journal-title":"J Cutan Aesthetic Surg"},{"key":"2863_CR41","doi-asserted-by":"crossref","unstructured":"Osaki TH, Osaki MH (2019) Management of diffuse xanthelasma palpebrarum using trichloroacetic acid application to reduce lesions followed by surgical excision. Aesthet Surg J. 39:NP6\u20138","DOI":"10.1093\/asj\/sjy268"},{"key":"2863_CR42","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2020.02.018","volume":"83","author":"L Bik","year":"2020","unstructured":"Bik L, Sangers T, Greveling K, Prens E, Haedersdal M, van Doorn M (2020) Efficacy and tolerability of intralesional bleomycin in dermatology: a systematic review. J Am Acad Dermatol 83:888\u2013903","journal-title":"J Am Acad Dermatol"},{"key":"2863_CR43","unstructured":"Brandt JP, Gerriets V. Bleomycin (2023) StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555895\/. cited 2023 Jun 29"},{"key":"2863_CR44","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jocd.13258","volume":"19","author":"X Lin","year":"2020","unstructured":"Lin X, Hu H, Qian Y, Jie X, Nie B, Zhao Y-Z et al (2020) Intralesional injection of bleomycin in the treatment of xanthelasma palpebrarum: a clinical study. J Cosmet Dermatol 19:2125\u20132130","journal-title":"J Cosmet Dermatol"},{"key":"2863_CR45","first-page":"368","volume":"42","author":"H Wang","year":"2016","unstructured":"Wang H, Shi Y, Guan H, Liu C, Zhang W, Zhang Y et al (2016) Treatment of xanthelasma palpebrarum with intralesional pingyangmycin. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 42:368\u2013376","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"2863_CR46","doi-asserted-by":"crossref","unstructured":"Azendour H, Alami S, Meziane M, Ismaili N, Benzekri L, Senouci K (2022) Treatment of xanthelasma palpebrarum with intralesional heparin sodium: a pilot study. Int J Dermatol","DOI":"10.1111\/ijd.16509"},{"key":"2863_CR47","volume":"31","author":"J Ren","year":"2018","unstructured":"Ren J, Zeng L-Y, Chen M-H (2018) Treatment of Grade I and II types of xanthelasma palpebrarum with intralesional heparin sodium. Dermatol Ther 31:e12723","journal-title":"Dermatol Ther"},{"key":"2863_CR48","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1194\/jlr.E800008-JLR200","volume":"49","author":"AS Peterson","year":"2008","unstructured":"Peterson AS, Fong LG, Young SG (2008) PCSK9 function and physiology. J Lipid Res 49:1152\u20131156","journal-title":"J Lipid Res"},{"key":"2863_CR49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/17512433.2017.1318063","volume":"10","author":"G Della Pepa","year":"2017","unstructured":"Della Pepa G, Bozzetto L, Annuzzi G, Rivellese AA (2017) Alirocumab for the treatment of hypercholesterolaemia. Expert Rev Clin Pharmacol 10:571\u2013582","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2863_CR50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacl.2016.07.007","volume":"10","author":"F Civeira","year":"2016","unstructured":"Civeira F, Perez-Calahorra S, Mateo-Gallego R (2016) Rapid resolution of xanthelasmas after treatment with alirocumab. J Clin Lipidol 10:1259\u20131261","journal-title":"J Clin Lipidol"},{"key":"2863_CR51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/L19-0797","volume":"172","author":"J Lazarte","year":"2020","unstructured":"Lazarte J, Hegele RA (2020) Regression of xanthelasmas with statin treatment in a normolipidemic patient. Ann Intern Med 172:701\u2013702","journal-title":"Ann Intern Med"},{"key":"2863_CR52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40273-015-0355-y","volume":"34","author":"WS Weintraub","year":"2016","unstructured":"Weintraub WS, Gidding SS (2016) PCSK9 inhibitors: a technology worth paying for? Pharmacoeconomics 34:217\u2013220","journal-title":"Pharmacoeconomics"},{"key":"2863_CR53","volume":"13","author":"S Zha","year":"2022","unstructured":"Zha S, Yu X, Wang X, Gu Y, Tan Y, Lu Y et al (2022) Topical simvastatin improves lesions of diffuse normolipemic plane xanthoma by inhibiting foam cell pyroptosis. Front Immunol 13:865704","journal-title":"Front Immunol"},{"key":"2863_CR54","doi-asserted-by":"crossref","unstructured":"Howard H, Adelson D (2015) Xanthoma disseminatum treated with lipid-lowering agents: A case report and review of the literature. J Am Acad Dermatol 72:AB1","DOI":"10.1016\/j.jaad.2015.02.013"},{"key":"2863_CR55","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/09546634.2020.1775776","volume":"33","author":"F Al-Niaimi","year":"2022","unstructured":"Al-Niaimi F (2022) Ultrapulsed CO2 ablation in the treatment of xanthelasma palpebrarum: high satisfaction treatment with low recurrence. J Dermatol Treat 33:1116\u20131118","journal-title":"J Dermatol Treat"},{"key":"2863_CR56","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s10103-014-1664-7","volume":"30","author":"B Corradino","year":"2015","unstructured":"Corradino B, Di Lorenzo S, Triolo A, Moschella F (2015) Laser treatment of giant xanthelasma palpebrarum. Lasers Med Sci 30:2205\u20132207","journal-title":"Lasers Med Sci"},{"key":"2863_CR57","first-page":"1349","volume":"40","author":"SM Esmat","year":"2014","unstructured":"Esmat SM, Elramly AZ, Abdel Halim DM, Gawdat HI, Taha HI (2014) Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial. Dermatol Surg Off Publ Am Soc Dermatol Surg Al 40:1349\u20131355","journal-title":"Dermatol Surg Off Publ Am Soc Dermatol Surg Al"},{"key":"2863_CR58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/photob.2018.4580","volume":"37","author":"D Li","year":"2019","unstructured":"Li D, Lin S-B, Cheng B (2019) CO2 laser treatment of xanthelasma palpebrarum in skin types III\u2013IV: efficacy and complications after 9-month follow-up. Photobiomodulation Photomed Laser Surg 37:244\u2013247","journal-title":"Photobiomodulation Photomed Laser Surg"},{"key":"2863_CR59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0974-2077.155084","volume":"8","author":"V Pathania","year":"2015","unstructured":"Pathania V, Chatterjee M (2015) Ultrapulse carbon dioxide laser ablation of xanthelasma palpebrarum: a case series. J Cutan Aesthetic Surg 8:46\u201349","journal-title":"J Cutan Aesthetic Surg"},{"key":"2863_CR60","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/jocd.14166","volume":"20","author":"A Liu","year":"2021","unstructured":"Liu A, Kollipara R, Hoss E, Goldman MP (2021) Lower eyelid xanthelasma following hyaluronic acid filler injections to the tear troughs. J Cosmet Dermatol 20:3190\u20133192","journal-title":"J Cosmet Dermatol"},{"key":"2863_CR61","first-page":"4803168","volume":"2020","author":"EJ Choi","year":"2020","unstructured":"Choi EJ, Oh TM, Han HH (2020) A modified surgical method combined with blepharoplasty design for treatment of xanthelasma palpebrarum. BioMed Res Int 2020:4803168","journal-title":"BioMed Res Int"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02863-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02863-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:49:09Z","timestamp":1717494549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02863-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["2863"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02863-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"assertion":[{"value":"29 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no commercial or other associations that might pose a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"149"}}